Learnings from cross-border biosimilar pricing policies in Europe

Expert Rev Pharmacoecon Outcomes Res. 2024 Jun;24(5):585-588. doi: 10.1080/14737167.2024.2334343. Epub 2024 Mar 26.
No abstract available

Keywords: Biosimilar; europe; policy; price; procurement; sustainability.

Publication types

  • Editorial

MeSH terms

  • Biosimilar Pharmaceuticals* / economics
  • Costs and Cost Analysis
  • Drug Costs*
  • Europe
  • Humans

Substances

  • Biosimilar Pharmaceuticals